EVOLENT HEALTH INC - A (EVH) Stock Analyst Earnings Estimates
NYSE:EVH - New York Stock Exchange, Inc. - US30050B1017 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.352B 48.90% | 1.964B 45.26% | 2.555B 30.09% | 2.131B -16.59% | 2.451B 15.02% | 2.822B 15.14% | 4.488B 59.04% | 3.808B -15.15% | 4.15B 8.98% | 4.512B 8.72% | |
| EBITDA YoY % growth | 70.8M 301.36% | 136.212M 92.39% | 115.795M -14.99% | 167.66M 44.79% | 200.51M 19.59% | 353.48M 76.29% | 392.16M 10.94% | 376.63M -3.96% | 446.82M 18.64% | 525.3M 17.56% | |
| EBIT YoY % growth | 3.6M 108.49% | 12.797M 255.47% | -2.575M -120.12% | 71.665M 2,883.11% | 107.25M 49.65% | 326.71M 204.62% | 395.56M 21.07% | 460.86M 16.51% | 538.43M 16.83% | N/A | |
| Operating Margin | 0.27% | 0.65% | -0.10% | 3.36% | 4.38% | 11.58% | 8.81% | 12.10% | 12.97% | N/A | |
| EPS YoY % growth | 0.91 4,450.00% | 0.88 -3.30% | 0.66 -25.00% | 0.58 -12.80% | 0.82 42.60% | 1.79 117.83% | 2.19 22.60% | N/A | N/A | N/A |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 -72.08% | 0.12 -59.73% | 0.13 215.37% | 0.13 757.00% | 0.16 63.83% | 0.18 50.50% | 0.19 52.12% | 0.19 42.97% | 0.21 36.36% | 0.23 25.00% | 0.25 31.58% | 0.26 37.10% |
| Revenue Q2Q % growth | 479.2M -25.08% | 521.13M -19.47% | 553.05M -11.00% | 577.41M -10.69% | 572.11M 19.39% | 599.76M 15.09% | 613.52M 10.93% | 633.4M 9.70% | 627.73M 9.72% | 645.55M 7.63% | 665.84M 8.53% | 687.28M 8.51% |
| EBITDA Q2Q % growth | 34.34M 108.20% | 37.986M -44.19% | 39.597M -48.31% | 41.04M -69.05% | 44.828M 30.54% | 46.832M 23.29% | 46.625M 17.75% | 44.458M 8.33% | 52.737M 17.64% | 56.166M 19.93% | 60.036M 28.76% | 61.542M 38.43% |
| EBIT Q2Q % growth | 13.615M 204.66% | 17.503M 101.46% | 18.206M 246.02% | 19.233M 35.31% | 24.599M 80.68% | 27.327M 56.13% | 28.913M 58.81% | 29.119M 51.40% | 40.128M 63.13% | 43.391M 58.78% | 47.085M 62.85% | 48.403M 66.22% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.02 -108.70% | 0.01 | -0.03 | -332.96% |
| Q3 2024 Q2Q % growth | 0.04 -86.67% | 0.34 | -0.30 | -88.41% |
| Q2 2024 Q2Q % growth | 0.30 114.29% | 0.26 | 0.04 | 17.44% |
| Q1 2024 Q2Q % growth | 0.34 61.90% | 0.24 | 0.10 | 39.63% |
| Q4 2023 Q2Q % growth | 0.23 130.00% | 0.15 | 0.08 | 52.95% |
| Q3 2023 Q2Q % growth | 0.30 -49.15% | 0.07 | 0.23 | 333.18% |
| Q2 2023 Q2Q % growth | 0.14 40.00% | 0.11 | 0.03 | 22.82% |
| Q1 2023 Q2Q % growth | 0.21 75.00% | 0.20 | 0.01 | 2.68% |
| Q4 2022 Q2Q % growth | 0.10 25.00% | 0.17 | -0.07 | -39.73% |
| Q3 2022 Q2Q % growth | 0.59 2,066.67% | 0.12 | 0.47 | 392.67% |
| Q2 2022 Q2Q % growth | 0.10 600.00% | 0.05 | 0.05 | 103.85% |
| Q1 2022 Q2Q % growth | 0.12 1,300.00% | 0.00 | 0.12 | 6,040.59% |
| Q4 2021 Q2Q % growth | 0.08 900.00% | 0.01 | 0.07 | 850.88% |
| Q3 2021 Q2Q % growth | -0.03 | -0.03 | 0.00 | 9.61% |
| Q2 2021 Q2Q % growth | -0.02 33.33% | -0.04 | 0.02 | 44.99% |
| Q1 2021 Q2Q % growth | -0.01 92.86% | -0.07 | 0.06 | 84.77% |
| Q4 2020 Q2Q % growth | -0.01 85.71% | -0.05 | 0.04 | 78.59% |
| Q3 2020 Q2Q % growth | -0.03 66.67% | -0.04 | 0.01 | 32.49% |
| Q2 2020 Q2Q % growth | -0.03 88.46% | -0.10 | 0.07 | 70.02% |
| Q1 2020 Q2Q % growth | -0.14 54.84% | -0.13 | -0.01 | -5.72% |
| Q4 2019 Q2Q % growth | -0.07 | -0.04 | -0.03 | -92.52% |
| Q3 2019 Q2Q % growth | -0.09 | -0.13 | 0.04 | 28.76% |
| Q2 2019 Q2Q % growth | -0.26 | -0.23 | -0.03 | -13.83% |
| Q1 2019 Q2Q % growth | -0.31 | -0.34 | 0.03 | 7.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 646.542M 16.27% | 657.7M | -11.158M | -1.70% |
| Q3 2024 Q2Q % growth | 621.401M 21.60% | 633.42M | -12.019M | -1.90% |
| Q2 2024 Q2Q % growth | 647.145M 37.94% | 642.8M | 4.345M | 0.68% |
| Q1 2024 Q2Q % growth | 639.653M 49.56% | 606.83M | 32.823M | 5.41% |
| Q4 2023 Q2Q % growth | 556.055M 45.41% | 547.82M | 8.235M | 1.50% |
| Q3 2023 Q2Q % growth | 511.015M 44.93% | 514.33M | -3.315M | -0.64% |
| Q2 2023 Q2Q % growth | 469.136M 46.65% | 465.31M | 3.826M | 0.82% |
| Q1 2023 Q2Q % growth | 427.69M 43.95% | 438.68M | -10.99M | -2.51% |
| Q4 2022 Q2Q % growth | 382.4M 53.95% | 376.66M | 5.74M | 1.52% |
| Q3 2022 Q2Q % growth | 352.6M 58.47% | 360.34M | -7.74M | -2.15% |
| Q2 2022 Q2Q % growth | 319.9M 44.03% | 300.82M | 19.08M | 6.34% |
| Q1 2022 Q2Q % growth | 297.1M 38.12% | 289.64M | 7.46M | 2.58% |
| Q4 2021 Q2Q % growth | 248.4M 0.77% | 236.22M | 12.18M | 5.16% |
| Q3 2021 Q2Q % growth | 222.5M -7.14% | 227.88M | -5.38M | -2.36% |
| Q2 2021 Q2Q % growth | 222.1M 2.21% | 219.09M | 3.01M | 1.37% |
| Q1 2021 Q2Q % growth | 215.1M -2.76% | 214.92M | 180K | 0.08% |
| Q4 2020 Q2Q % growth | 246.5M 218.89% | 264.17M | -17.67M | -6.69% |
| Q3 2020 Q2Q % growth | 239.6M 8.86% | 266.41M | -26.81M | -10.06% |
| Q2 2020 Q2Q % growth | 217.3M 13.18% | 243.44M | -26.14M | -10.74% |
| Q1 2020 Q2Q % growth | 221.2M 11.83% | 241.5M | -20.3M | -8.41% |
| Q4 2019 Q2Q % growth | 77.3M | 235.19M | -157.89M | -67.13% |
| Q3 2019 Q2Q % growth | 220.1M | 220.08M | 20K | 0.01% |
| Q2 2019 Q2Q % growth | 192M | 194.53M | -2.53M | -1.30% |
| Q1 2019 Q2Q % growth | 197.8M | 194.63M | 3.17M | 1.63% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -32.76% | -58.12% | -21.56% | -40.76% |
| Revenue | -21.15% | -33.3% | -12.77% | -27.96% |